The QseB response regulator imparts tolerance to positively charged antibiotics by controlling metabolism and minor changes to LPS.

Autor:	Hurst MN; Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA., Beebout CJ; Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA., Hollingsworth A; Department of Biological Sciences, Vanderbilt University , Nashville, Tennessee, USA., Guckes KR; Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA., Purcell A; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia , Athens, Georgia, USA., Bermudez TA; Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA., Williams D; Department of Biological Sciences, Vanderbilt University , Nashville, Tennessee, USA., Reasoner SA; Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA., Trent MS; Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia , Athens, Georgia, USA., Hadjifrangiskou M; Division of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA.; Vanderbilt Institute for Infection, Immunology and Inflammation , Nashville, Tennessee, USA.; Center for Personalized Microbiology, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center , Nashville, Tennessee, USA.
Jazyk:	angličtina
Zdroj:	MSphere [mSphere] 2023 Oct 24; Vol. 8 (5), pp. e0005923. Date of Electronic Publication: 2023 Sep 07.
DOI:	10.1128/msphere.00059-23
Abstrakt:	The modification of lipopolysaccharide (LPS) in Escherichia coli and Salmonella spp. is primarily controlled by the two-component system PmrAB. LPS modification allows bacteria to avoid killing by positively charged antibiotics like polymyxin B (PMB). We previously demonstrated that in uropathogenic E. coli (UPEC), the sensor histidine kinase PmrB also activates a non-cognate transcription factor, QseB, and this activation somehow augments PMB tolerance in UPEC. Here, we demonstrate-for the first time-that in the absence of the canonical LPS transcriptional regulator, PmrA, QseB can direct some modifications on the LPS. In agreement with this observation, transcriptional profiling analyses demonstrate regulatory overlaps between PmrA and QseB in terms of regulating LPS modification genes. However, both PmrA and QseB must be present for UPEC to mount robust tolerance to PMB. Transcriptional and metabolomic analyses also reveal that QseB transcriptionally regulates the metabolism of glutamate and 2-oxoglutarate, which are consumed and produced during the modification of lipid A. We show that deletion of qseB alters glutamate levels in the bacterial cells. The qseB deletion mutant, which is susceptible to positively charged antibiotics, is rescued by exogenous addition of 2-oxoglutarate. These findings uncover a previously unknown mechanism of metabolic control of antibiotic tolerance that may be contributing to antibiotic treatment failure in the clinic. IMPORTANCE Although antibiotic prescriptions are guided by well-established susceptibility testing methods, antibiotic treatments oftentimes fail. The presented work is significant because it uncovers a mechanism by which bacteria transiently avoid killing by antibiotics. This mechanism involves two closely related transcription factors, PmrA and QseB, which are conserved across Enterobacterales . We demonstrate that PmrA and QseB share regulatory targets in lipid A modification pathway and prove that QseB can orchestrate modifications of lipid A in Escherichia coli in the absence of PmrA. Finally, we show that QseB controls glutamate metabolism during the antibiotic response. These results suggest that rewiring of QseB-mediated metabolic genes could lead to stable antibiotic resistance in subpopulations within the host, thereby contributing to antibiotic treatment failure. Competing Interests: The authors declare no conflict of interest.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu